DNA hypomethylation in breast cancer: An independent parameter of tumor progression?

Cancer Genetics and Cytogenetics

Volumn 97, Issue 2, 1997, Pages 83-89

  Bernardino, J ^a   Roux, C ^a   Almeida, A ^a   Vogt, N ^a   Gibaud, A ^a   Gerbault Seureau, M ^a   Magdelenat, H ^b   Bourgeois, C A ^c   Malfoy, B ^a   Dutrillaux, B ^a  

^a CNRS   (France)

^b INSTITUT CURIE   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

STEROID RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GRADING; CARCINOGENICITY; CELL PROLIFERATION; DNA CONTENT; DNA METHYLATION; GENE LOCATION; HUMAN; HUMAN TISSUE; KARYOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGE FACTORS; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; LYMPHATIC METASTASIS; MENSTRUATION; PLOIDIES; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0030854016     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00385-8     Document Type: Article

References (33)

1. Jones PA, Buckley JD (1990): The role of DNA methylation in cancer. Adv Cancer Res 54:1-23.
2. de Bustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, Baylin SB (1988): The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci 85:5693-5697.
3. Antequera F, Boyes J, Bird A (1990): High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62:503-514.
4. Jones PA, Wolkowicz MJ, Rideout III WM, Gonzales FA, Marziasz CM, Coetzee GA, Tapscott SJ (1990): De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87:6117-6121.
5. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B, Baylin SB (1992): Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 89:1929-1933.
6. Lapeyre JN, Walker MS, Becker FF (1981): DNA methylation and methylase levels in normal and malignant mouse hepatic tissues. Carcinogenesis 2:873-878.
7. Kautainien TL, Jones PA (1986): DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J Biol Chem 261:1594-1598.
8. El-Deiry WS, Nelkin BD, Celano P, Yen RWC, Falco JP, Hamilton SR, Baylin SB (1991): High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88:3470-3474.
9. Issa JPJ, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, Hamilton SR, Baylin SB (1993): Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85:1235-1240.
10. Laird PW, Jackson-Grusby L, Fazelli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R (1995): Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205.
11. MacLeod AR, Szyf M (1995): Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem 270:8037-8043.
12. Wu J, Issa JP, Herman J, Bassett Jr DE, Nelkin BD, Baylin SB (1993): Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 80:8891-8895.
13. Greger V, Passarge E, Höpping W, Messmer E, Horsthemke B (1989): Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83:155-158.
14. Herman JG, Latif F, Weng Y, Lerman LI, Zbar B, Liu S, Samid D, Duan DSR, Gnarra JR, Linehan WM, Baylin SB (1994): Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704.
15. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPJ, Davidson NE, Sidransky D, Baylin SB (1995): Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530.
16. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995): 5'CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancer. Nature Med 1:686-695.
17. INK4 protein induction by 5-aza 2'deoxycytidine. Oncogene 11:1211-1216.
18. Costello JF, Berger MS, Su Huang HJ, Cavenee WK (1996): Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56:2405-2410.
19. Makos Wales M, Biel MA, El Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB (1995): p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Medicine 1:570-577.
20. Cheah MSC, Wallace CD, Huffman RM (1984): Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J Natl Cancer Inst 73:1057-1065.
21. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP (1985): DNA from benign and malignant human colon neoplasms is hypomethylated. Science 228:187-190.
22. Feinberg AP, Vogelstein B (1983): Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 111:47-54.
23. Vachtenheim J, Horakova I, Novotna H (1994): Hypomethylation of CCGG sites in the 3′ region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer. Cancer Res 54:1145-1148.
24. Fearon ER, Vogelstein B (1990): A genetic model for colorectal tumorigenesis. Cell 61:759-767.
25. Baylin SB, Makos M, Wu J, Chiu Yen RW, de Bustros A, Vertino P, Nelkin BD (1991): Abnormal patterns of DNA methylation in humanneoplasia: potential consequences for tumor progression. Cancer Cells 3:383-390.
26. Dutrillaux B, Gerbault-Seureau M, Remvikos Y, Zafrani B, Prieur M (1991): Breast cancer genetic evolution: I. Data from cytogenesis and DNA content. Breast Cancer Res Treat 19:245-255.
27. Magdelenat H, Cerbault-Seureau M, Laine-Bidron G, Prieur M, Dutrillaux B (1992): Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression. Breast Cancer Res Treat 22:119-127.
28. Remvikos Y, Gerbault-Seureau M, Magdelenat H, Prieur M, Dutrillaux B (1992): Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis. Breast Cancer Res Treat 23:43-49.
29. Bloom HJG, Richardson WW (1957): Histological grading and prognosis in breast cancer. Br J Cancer 11:359-366.
30. Remvikos Y, Magdelenat H, Dutrillaux B (1995): Genetic evolution of breast cancers III: Age-dependent variations in the correlations between biological indicators of prognosis. Breast Cancer Res Treat 34:25-33.
31. Pandis N, Idvall I, Bardi G, Jin Y, Gorunova L, Mertens F, Olsson H, Ingvar C, Beroukas K, Mitelman F, Heim S (1996): Correlation between karyotypic pattern and clinicopathologic features in 125 breast cancer cases. Int J Cancer 66:191-196.
32. Dutrillaux B (1995): Pathways of chromosome alteration in human epithelial cancers. Adv Cancer Res 67:59-82.
33. Romain S, Laine Bidron C, Martin PM, Magdelenat H (1995): Steroid receptor distribution in 47892 breast cancers. A collaborative study of 7 European laboratories. Eur J Cancer 31A:411-417.